No medical or therapeutic claims are made or implied
Since Clinical Policy Bulletins (CPBs) can be highly technical and are designed to be used by our professional staff in making clinical determinations in connection with coverage decisions, members should review these Bulletins with their providers so they may fully understand our policies
Unlike HGH, AOD 9604 has no growth-promoting effects, which makes it safer to use as part of a targeted therapy plan
Matsuzaki M, Ellis-Davies GC, Nemoto T, Miyashita Y, Iino M, Kasai H (2001)
Add your clinical experience in the comments for community discussion
The rationale is mechanistic: the two compounds operate through distinct but non-overlapping pathways, with tissue targets that complement rather than duplicate each other